Excelsior Medical Co., Ltd. (TPE:4104)
78.00
-0.70 (-0.89%)
Feb 2, 2026, 1:35 PM CST
Excelsior Medical Revenue
Excelsior Medical had revenue of 2.19B TWD in the quarter ending September 30, 2025, with 6.44% growth. This brings the company's revenue in the last twelve months to 8.79B, up 4.04% year-over-year. In the year 2024, Excelsior Medical had annual revenue of 8.54B with 3.71% growth.
Revenue (ttm)
8.79B
Revenue Growth
+4.04%
P/S Ratio
1.54
Revenue / Employee
63.67M
Employees
138
Market Cap
13.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.54B | 305.14M | 3.71% |
| Dec 31, 2023 | 8.23B | 1.05B | 14.56% |
| Dec 31, 2022 | 7.19B | 613.68M | 9.34% |
| Dec 31, 2021 | 6.57B | -102.34M | -1.53% |
| Dec 31, 2020 | 6.68B | 218.13M | 3.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| TaiDoc Technology | 4.34B |
| Universal Vision Biotechnology | 4.21B |
| Handa Pharmaceuticals | 1.62B |
| Ever Supreme Bio Technology | 1.01B |
| Medigen Vaccine Biologics | 594.96M |